Home/Filings/4/0001437749-14-017650
4//SEC Filing

NovaBay Pharmaceuticals, Inc. 4

Accession 0001437749-14-017650

$NBYCIK 0001389545operating

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:59 PM ET

Size

5.2 KB

Accession

0001437749-14-017650

Insider Transaction Report

Form 4
Period: 2014-09-26
Stroman David W.
SVP, Ophthalmic Product Devt.
Transactions
  • Award

    Option (right to buy)

    2014-09-26+50,000374,834 total
    Exercise: $0.75From: 2015-09-26Exp: 2024-09-26Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]Options granted pursuant to 2007 Omnibus Incentive Plan
  • [F2]25% will vest on the first anniversary of the Grant Date. 6.25% will vest every three months thereafter

Issuer

NovaBay Pharmaceuticals, Inc.

CIK 0001389545

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001389545

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:59 PM ET
Size
5.2 KB